One aspect of this study that should be emphasized is that this is a particularly unique, large dataset of BRCA pathogenic variant carriers treated with breast-conserving surgery, with many of the patients included in this study being unaware of their BRCA1/2 variant status at the time of their diagnosis and treatment for breast cancer. The gene discussed is BRCA1; the disease is breast cancer.